These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15537565)

  • 1. Interaction between nesiritide and a heparin-coated pulmonary artery line during an infusion for decompensated heart failure.
    Baroletti SA; Wahlstrom HD
    Pharmacotherapy; 2004 Nov; 24(11):1634-7. PubMed ID: 15537565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of nesiritide infusion via non-primed tubing and heparin-coated catheters.
    Onat D; Stathopoulos J; Rose A; Newman K; Sciacca RR; Jorde UP; Colombo PC
    Ann Pharmacother; 2005 Oct; 39(10):1617-20. PubMed ID: 16159995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
    Michaels AD; Chatterjee K; De Marco T
    J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).
    Yancy CW; Singh A
    Am J Cardiol; 2006 Jul; 98(2):226-9. PubMed ID: 16828598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experience with nesiritide in pediatric patients less than 12 months of age.
    Ryan A; Rosen DA; Tobias JD
    J Intensive Care Med; 2008; 23(5):321-8. PubMed ID: 18603536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
    Chow SL; Peng JT; Okamoto MP; Heywood JT
    Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics.
    Moffett BS; Jefferies JL; Price JF; Clunie S; Denfield S; Dreyer WJ; Towbin JA
    Pharmacotherapy; 2006 Feb; 26(2):277-80. PubMed ID: 16466333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
    Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
    J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
    Riter HG; Redfield MM; Burnett JC; Chen HH
    J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.
    Fitzgerald RL; Cremo R; Gardetto N; Chiu A; Clopton P; Bhalla V; Maisel AS
    Am Heart J; 2005 Sep; 150(3):471-7. PubMed ID: 16169326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of serial home infusions of nesiritide for advanced heart failure.
    Chung ES; Menon SG; Daly KA; Atkinson J; Peterson T; Robertson R; Ibanez K; Kereiakes DJ
    Am J Cardiol; 2006 May; 97(9):1370-3. PubMed ID: 16635613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial).
    Yancy CW; Saltzberg MT; Berkowitz RL; Bertolet B; Vijayaraghavan K; Burnham K; Oren RM; Walker K; Horton DP; Silver MA
    Am J Cardiol; 2004 Sep; 94(5):595-601. PubMed ID: 15342289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.